We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+7.06%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$25.9B
AUM Growth
+$1.75B
Cap. Flow
+$434M
Cap. Flow %
1.67%
Top 10 Hldgs %
23.48%
Holding
1,080
New
134
Increased
325
Reduced
445
Closed
139

Top Buys

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$189M
2
INTC icon
Intel
INTC
+$180M
3
APH icon
Amphenol
APH
+$132M
4
INTU icon
Intuit
INTU
+$106M
5
LUV icon
Southwest Airlines
LUV
+$86.2M

Top Sells

Rank Stock Value
1
FTNT icon
Fortinet
FTNT
+$221M
2
CEG icon
Constellation Energy
CEG
+$181M
3
UBER icon
Uber
UBER
+$169M
4
MA icon
Mastercard
MA
+$140M
5
EXC icon
Exelon
EXC
+$108M

Sector Composition

Rank Sector Weight
1 Technology 30.39%
2 Financials 14.25%
3 Consumer Discretionary 12.97%
4 Industrials 12.61%
5 Healthcare 10.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GRPN icon
926
Groupon
GRPN
$1.07B
$174K ﹤0.01%
+17,754
New +$238K
FFIC
927
DELISTED
Flushing Financial
FFIC
$171K ﹤0.01%
+11,735
New +$165K
HL icon
928
Hecla Mining
HL
$9.76B
$170K ﹤0.01%
+25,542
New +$149K
NXDR
929
Nextdoor Holdings
NXDR
$877M
$152K ﹤0.01%
+61,129
New +$157K
EXFY icon
930
Expensify
EXFY
$173M
$151K ﹤0.01%
76,945
-771,727
-91% -$1.6M
BIRD icon
931
Smartbird Inc
BIRD
$21M
$138K ﹤0.01%
+11,730
New +$148K
EGAN icon
932
eGain
EGAN
$190M
$107K ﹤0.01%
20,917
-3,046
-13% -$19.5K
LCUT icon
933
Lifetime Brands
LCUT
$200M
$102K ﹤0.01%
15,651
+425
+3% +$3.12K
KYTX icon
934
Kyverna Therapeutics
KYTX
$455M
$97.2K ﹤0.01%
+19,869
New +$153K
PACK icon
935
Ranpak Holdings
PACK
$550M
$92.5K ﹤0.01%
14,171
-218,848
-94% -$1.51M
ANTX icon
936
AN2 Therapeutics
ANTX
$169M
$84.9K ﹤0.01%
+79,359
New +$138K
EVC icon
937
Entravision Communication
EVC
$1.01B
$80.3K ﹤0.01%
+38,808
New +$77.5K
MAPS
938
DELISTED
WM TECHNOLOGY INC A
MAPS
$75.3K ﹤0.01%
+86,599
New +$86.2K
MASS icon
939
908 Devices
MASS
$288M
$46.8K ﹤0.01%
13,500
DHX icon
940
DHI Group
DHX
$178M
$44.4K ﹤0.01%
24,118
-164,108
-87% -$312K
OM icon
941
Outset Medical
OM
$87.5M
$37.4K ﹤0.01%
3,683
-22,731
-86% -$676K
AA icon
942
Alcoa
AA
$11.7B
-296,603
Closed -$11.8M
ADTN icon
943
Adtran
ADTN
$730M
-79,322
Closed -$417K
ADUS icon
944
Addus HomeCare
ADUS
$2.23B
-15,019
Closed -$1.74M
ALLO icon
945
Allogene Therapeutics
ALLO
$573M
-878,955
Closed -$2.05M
ALNY icon
946
Alnylam Pharmaceuticals
ALNY
$38.5B
-13,283
Closed -$3.23M
ALT icon
947
Altimmune
ALT
$581M
-86,949
Closed -$578K
ALTG icon
948
Alta Equipment Group
ALTG
$207M
-61,414
Closed -$494K
ALXO icon
949
ALX Oncology
ALXO
$268M
-232,022
Closed -$1.4M
AMPH icon
950
Amphastar Pharmaceuticals
AMPH
$888M
-28,616
Closed -$1.14M

Similar funds

Jacobs Levy Equity Management's Q3 2024 Portfolio in Review

As of Q3 2024, Jacobs Levy Equity Management held 1,080 positions worth $25.9B, up 7.2% from $24.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Jacobs Levy Equity Management's Q3 2024 filing shows 134 new, 325 increased, 445 reduced and 139 closed positions. Its largest new stake was Lam Research: 962,880 shares worth $78.6M. The largest sale was Fortinet, an estimated $221M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Jacobs Levy Equity Management's largest Q3 2024 buy was Lam Research: 962,880 shares worth $78.6M.
  • Jacobs Levy Equity Management added most to Edwards Lifesciences in Q3 2024, an estimated $189M increase.
  • Jacobs Levy Equity Management's biggest Q3 2024 reduction was Fortinet, cutting an estimated $221M.
  • Jacobs Levy Equity Management fully exited Smartsheet Inc. in Q3 2024, selling an estimated $81.1M.
  • Jacobs Levy Equity Management's ten largest holdings make up 23% of its $25.9B portfolio in Q3 2024.
  • Jacobs Levy Equity Management opened 134 new positions and closed 139 in Q3 2024.
  • Jacobs Levy Equity Management's portfolio value rose 7.2% quarter-over-quarter to $25.9B.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2024, filed 14 Nov 2024.